Position in HCM
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$3,474,399
+$497,411 QoQ
Shares Held
232,246
+4.0% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 54 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HCM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Amundi holds $607,665,967 across 23 Drug Manufacturers - Specialty & Generic names. HCM ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,166,361 | $374,295,531 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
147,599 | $87,523,254 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,765,686 | $53,182,461 | |
| 4 | VTRS |
Viatris Inc
|
3,407,023 | $46,028,880 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
203,637 | $26,827,137 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
78,456 | $5,950,886 | |
| 7 | HCM |
HUTCHMED (China) Ltd
This page
|
232,246 | $3,474,399 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
98,313 | $2,352,630 |
All Filings in HCM
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,474,399 | 232,246 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,976,988 | 223,330 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,517,446 | 223,330 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,369,351 | 157,432 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,367,777 | 157,432 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,453,302 | 170,250 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $3,396,148 | 173,894 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,977,064 | 173,894 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,232,860 | 251,956 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,447,874 | 135,167 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $625,102 | 36,901 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $442,812 | 36,901 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $480,451 | 36,901 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $545,396 | 36,901 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,098,294 | 236,828 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,927,776 | 231,628 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $6,543,138 | 345,832 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,122,577 | 288,557 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,417,814 | 284,562 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,382,407 | 289,850 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||